Eloxatin 50 mg injection Images
Generic Name: oxaliplatin
This medication has been identified as Eloxatin 50 mg injection. It is supplied by Sanofi.
Eloxatin is used in the treatment of Colorectal Cancer and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Eloxatin 50 mg injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eloxatin
- Generic Name
- oxaliplatin
- Strength
- 50 mg injection
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi
- National Drug Code (NDC)
- 00024-0590 (Discontinued)
More about Eloxatin (oxaliplatin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
